Every January, Dr. Joe Galati put together a series of wellness articles airmed at the general consumer, to give them ideas on how to think about their health differently. Below is the series - as of today, all on one page, to review and share with your friends and family. Starting the Year off RightBest Exercise App for Yor Phone Wellness and Gut Bacteria 7-Minutes to Fit: Great Little Exercise Book Don't Eat Packaged Food! Food Labels-BEWARE Reducing the Pill Count: Too Many Meds to Take Cancer Death Rate Down-Video Blog Sipping Ourselves to Death Avocado-Eat More
Dr. Rashid Khan just posted the top five reasons to be concerned with non-alcoholic fatty liver disease. A growing public health concern, fatty liver continues to cause a wide range of medical complication that need to be taken seriously. If you have fatty liver, you need further evaluation. Read his blog entry here.
Hepatic encephalopathy is a complication of advanced liver disease related to cirrhosis. It occures in all causes of cirrhosis, and is related to a build-up of toxins in the nervous system. A recent blog entry by Dr. Joe Galati outlines the top five symptoms that are seen. Read the blog entry here. AASLD Guidelines on Hepatic Encephalopathy for a more detailed review.
Save the date! Dr. Galati's first Town Hall Meeting, which is being called the "Wake-Up Call, will take place at Houston's Health Museum, on Thursday, November 5, 2015, starting at 6:00 p.m. Sponsored by Your Health First Education, the mission of this event is to provide the lay public with the tools necessary to engage themselves, and those closest to them, in a discussion of health and wellness. So many complications of various diseases could be prevented, or diagnosed earlier, reducing complications, and far better outcomes. This "wake-up call" is to tell everyone that being a bit more aware of their body, and better understanding of how it works, will lead to far improved health and happiness. Information about the event: Location: Houston Health Museum Address: 1515 Hermann Drive, Houston, Texas 77004 Time: 6:00 p.m. - 9:00 p.m. Free parking, …
A common question Dr. Joe Galati is asked regarding transplant is what the upper age limit is to be considered for transplant? Dr. Galati expains further in this video.
Today, the FDA approved the latest drug to treat hepatitis C. Manufactiured by Gilead, a combination of Ledipasvir and Sofosbuvir, it has a better than 95% cure rate. Called Harvoni, it will be available shortly for patients. For more information, call our office at 713-794-0700 for more details.
Our latest video posting discusses the basic aspects of alcohol, and its effects on the liver. You can view the video here on YouTube, or simply watch below. Additional links and information on alcohol can be found here.
Over the past several years, has been growing research evidence that individuals that have hepatitis C are at greater risk for developing scarring in the liver, fibrosis, and eventual development of cirrhosis. These patients also are likely to be overweight, have a superimposed fatty liver, diabetes, and increased levels of insulin circulating in their blood. All of these features trigger inflammation throughout the body, and especially in the liver, putting them at risk for damage and scar tissue development. We previously have discussed the role of diet and hepatitis C, and the simple truth is that there is no special diet specific for hepatitis C. We always recommend a diet high in fruits and vegetables, fresh lean meat, chicken, and fish, and the avoidance of processed foods. These processed foods are high and salt, sugar, and fat. They have very little …
Listed below are the updated hepatitis C research protocols that Liver Specialists of Texas and Dr. Galati are currently conducting. The studies are in various stages of enrollment, and some may have already met the limit of how many patients we can enroll. A PDF version is available here. New studies are being added every few weeks, so depending on your situation, and past experience with hepatitis C treatment, new opportunities may be available soon. Currently, the ongoing studies are making use of both interferon based therapies, as well as interferon-free therapies. It is probable that the next wave of FDA approvals will be for the interferon-free protocols. Kindly call Dee Wade at 713-794-0700 to inquire about hepatitis C research opportunities. Research Specialists of Texas List of Ongoing Studies No. Sponsor Protocol # Protocol …